Download Full Text (714 KB)
As of 2015, 9.4% of the US population had a diagnosis of Diabetes Mellitus (DM). Although most of the data sets studied encompass type 1 (T1) and type 2 (T2) DM data in all ages of patients, the focus of this project will be primarily on T1DM.
There are effective methods currently available for the management of T1DM patients. These methods include: closed-loop insulin pumps that integrate a continuous glucose monitor (CGM) and insulin pump into one effective system that calculates the needed insulin doses through complicated algorithms, CGM with self-blood glucose monitoring calibrations (SBGM) and insulin administration, and SBGM with insulin administration.
Literature reveals that closed-loop insulin pumps have the potential to provide better disease management and improved disease outcomes for those patients who are motivated to use them as directed and find them a desirable option.
When patients can effectively manage their blood glucose, and practice healthy lifestyle and dietary choices, they can avoid unnecessary hospitalizations and long-term diabetic complications. This will simultaneously reduce healthcare-related costs, increase longevity and can improve the patient’s quality of life.
Type 1 Diabetes Mellitus; T1DM; pathophysiology; continuous glucose monitoring; closed loop insulin delivery; artificial pancreas; glycemic control; hypoglycemia; insulin dependent; diabetes control and complications trial; DCCT
Endocrinology, Diabetes, and Metabolism
Daley, Kelsey, "Glycemic Control and Type 1 Diabetes Mellitus: Current Standard Treatment vs. Closed-Loop Insulin Pumps" (2018). Physician Assistant Scholarly Project Posters. 10.